Laxmi Dental Ltd is a end-to-end integrated dental products company. It products include custom-made crowns and bridges, branded dental products such as clear aligners, thermoforming sheets and aligner related products as a part of aligner solutions, and paediatric dental products. The Group has 3 reportable segment: Laboratory Business segment comprises of Dental Prosthesis such as metal free crowns & bridges, Porcelain Fused to Metal (PFM) Crowns and Bridges Denture. Aligners Business segment comprises of Dental Aligners, Retainers, Raw Materials for Aligners, Sport Guards, Night Guards, Sleep Apnea Devices. Other Business segment comprises of Dental distribution products used in Dental Laboratory, Dental Clinical Services and Dental Educational Courses.
2004
2.4K+
LTM Revenue $29.3M
LTM EBITDA $5.4M
$236M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Laxmi Dental has a last 12-month revenue (LTM) of $29.3M and a last 12-month EBITDA of $5.4M.
In the most recent fiscal year, Laxmi Dental achieved revenue of $27.7M and an EBITDA of $6.1M.
Laxmi Dental expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Laxmi Dental valuation multiples based on analyst estimatesLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue | $29.3M | XXX | $27.7M | XXX | XXX | XXX |
Gross Profit | $22.3M | XXX | $21.0M | XXX | XXX | XXX |
Gross Margin | 76% | XXX | 76% | XXX | XXX | XXX |
EBITDA | $5.4M | XXX | $6.1M | XXX | XXX | XXX |
EBITDA Margin | 18% | XXX | 22% | XXX | XXX | XXX |
EBIT | $3.5M | XXX | $3.1M | XXX | XXX | XXX |
EBIT Margin | 12% | XXX | 11% | XXX | XXX | XXX |
Net Profit | $3.5M | XXX | $3.7M | XXX | XXX | XXX |
Net Margin | 12% | XXX | 13% | XXX | XXX | XXX |
Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Laxmi Dental's stock price is INR 384 (or $4).
Laxmi Dental has current market cap of INR 21.1B (or $247M), and EV of INR 20.1B (or $236M).
See Laxmi Dental trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$236M | $247M | XXX | XXX | XXX | XXX | $0.06 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Laxmi Dental has market cap of $247M and EV of $236M.
Laxmi Dental's trades at 8.9x EV/Revenue multiple, and 44.2x EV/EBITDA.
Equity research analysts estimate Laxmi Dental's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Laxmi Dental has a P/E ratio of 70.6x.
See valuation multiples for Laxmi Dental and 12K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Market cap (current) | $247M | XXX | $247M | XXX | XXX | XXX |
EV (current) | $236M | XXX | $236M | XXX | XXX | XXX |
EV/Revenue | 8.1x | XXX | 8.9x | XXX | XXX | XXX |
EV/EBITDA | 44.1x | XXX | 44.2x | XXX | XXX | XXX |
EV/EBIT | 66.7x | XXX | 84.3x | XXX | XXX | XXX |
EV/Gross Profit | 10.6x | XXX | n/a | XXX | XXX | XXX |
P/E | 70.6x | XXX | 70.3x | XXX | XXX | XXX |
EV/FCF | 71.3x | XXX | 105.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialLaxmi Dental's last 12 month revenue growth is 27%
Laxmi Dental's revenue per employee in the last FY averaged $12K, while opex per employee averaged $8K for the same period.
Laxmi Dental's rule of 40 is 47% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Laxmi Dental's rule of X is 85% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Laxmi Dental and other 12K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue Growth | 27% | XXX | 27% | XXX | XXX | XXX |
EBITDA Margin | 18% | XXX | 20% | XXX | XXX | XXX |
EBITDA Growth | 52% | XXX | 38% | XXX | XXX | XXX |
Rule of 40 | 47% | XXX | 47% | XXX | XXX | XXX |
Bessemer Rule of X | XXX | XXX | 85% | XXX | XXX | XXX |
Revenue per Employee | XXX | XXX | $12K | XXX | XXX | XXX |
Opex per Employee | XXX | XXX | $8K | XXX | XXX | XXX |
S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
Opex to Revenue | XXX | XXX | 64% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Philips | XXX | XXX | XXX | XXX | XXX | XXX |
Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Laxmi Dental acquired XXX companies to date.
Last acquisition by Laxmi Dental was XXXXXXXX, XXXXX XXXXX XXXXXX . Laxmi Dental acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free TrialWhen was Laxmi Dental founded? | Laxmi Dental was founded in 2004. |
Where is Laxmi Dental headquartered? | Laxmi Dental is headquartered in India. |
How many employees does Laxmi Dental have? | As of today, Laxmi Dental has 2.4K+ employees. |
Is Laxmi Dental publicy listed? | Yes, Laxmi Dental is a public company listed on NSE. |
What is the stock symbol of Laxmi Dental? | Laxmi Dental trades under LAXMIDENTL ticker. |
When did Laxmi Dental go public? | Laxmi Dental went public in 2025. |
Who are competitors of Laxmi Dental? | Similar companies to Laxmi Dental include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
What is the current market cap of Laxmi Dental? | Laxmi Dental's current market cap is $247M |
What is the current revenue of Laxmi Dental? | Laxmi Dental's last 12 months revenue is $29.3M. |
What is the current revenue growth of Laxmi Dental? | Laxmi Dental revenue growth (NTM/LTM) is 27%. |
What is the current EV/Revenue multiple of Laxmi Dental? | Current revenue multiple of Laxmi Dental is 8.1x. |
Is Laxmi Dental profitable? | Yes, Laxmi Dental is EBITDA-positive (as of the last 12 months). |
What is the current EBITDA of Laxmi Dental? | Laxmi Dental's last 12 months EBITDA is $5.4M. |
What is Laxmi Dental's EBITDA margin? | Laxmi Dental's last 12 months EBITDA margin is 18%. |
What is the current EV/EBITDA multiple of Laxmi Dental? | Current EBITDA multiple of Laxmi Dental is 44.1x. |
What is the current FCF of Laxmi Dental? | Laxmi Dental's last 12 months FCF is $3.3M. |
What is Laxmi Dental's FCF margin? | Laxmi Dental's last 12 months FCF margin is 11%. |
What is the current EV/FCF multiple of Laxmi Dental? | Current FCF multiple of Laxmi Dental is 71.3x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.